Airflow limitation due to COPD despite tuberculosis sequellae Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis Year: 2011
Response of lung volumes in chronic obstructive pulmonary disease patients with improvement of airflow limitation Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Diagnosis of initial mild airway obstruction in the patients with pulmonary tuberculosis by the forced oscillation technique Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
The effect of pulmonary rehabilitation on expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
Impact of pulmonary tuberculosis on COPD outcomes Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021
Pulmonary function and blood gases in asthma and COPD with partially irreversible airflow limitation Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001
Pulmonary artery hypertension and severity of airflow limitation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006
Targeting therapy to the site of airflow limitation in COPD Source: International Congress 2019 – Putting COPD patient needs first: Time for optimizing treatment and device selection Year: 2019
Treatment results in patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002
Antioxidant status and pulmonary function in patients with chronic airflow limitation Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003
Lung comparative function in COPD patients and in patients with chronic airflow obstruction due to tuberculosis lung disorder Source: Eur Respir J 2006; 28: Suppl. 50, 130s Year: 2006
Impacts of bronchiectasis in asthma patients with airflow limitation Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET Source: ERJ Open Res, 6 (3) 00092-2020; 10.1183/23120541.00092-2020 Year: 2020
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Reversibility of airflow limitation in elderly patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 336s Year: 2007
Mechanisms of exercise limitation in patients with combined fibrosis and pulmonary emphysema Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017
Reasons why pulmonary pressure increases in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019
Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012